IDENTIFICATION OF ALPHA(1)-ADRENOCEPTOR SUBTYPES IN RAT RENAL PROXIMAL TUBULES

被引:10
作者
GOPALAKRISHNAN, SM [1 ]
CHEN, CJ [1 ]
LOKHANDWALA, MF [1 ]
机构
[1] UNIV HOUSTON,COLL PHARM,HOUSTON,TX 77204
关键词
ALPHA-1-ADRENOCEPTOR; RENAL PROXIMAL TUBULE; PRAZOSIN; ADRENOCEPTOR SUBTYPE;
D O I
10.1016/0014-2999(93)90036-H
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although the existence of alpha(1)-adrenoceptor subtypes has been suggested in the kidney, their characterization in the proximal tubules has not been reported. This study was undertaken to characterize the alpha(1)-adrenoceptor subtypes in the renal proximal tubules. [H-3]Prazosin bound to proximal tubules with a K-D of 106+/-17 pM and a B-max of 152+/-9 fmol/mg protein. Pretreatment of the tubules with chloroethylclonidine, 100 mu M, reduced the B-max of [H-3]prazosin binding by about 50%, indicating the presence of the alpha(1B)-adrenoceptor subtype. Competition studies performed with the alpha-adrenoceptor antagonists, WB 4101, (+)-niguldipine, 5-methylurapidil and phentolamine were shallow and could be distinguished into a high affinity (alpha(1A)) and a low affinity site (alpha(1B)) with an approximately equal distribution of both receptor subtypes. These observations clearly demonstrate the existence of alpha(1A)- and alpha(1B)-adrenoceptor subtypes in the renal proximal tubules.
引用
收藏
页码:469 / 472
页数:4
相关论文
共 15 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   SUBTYPES OF ALPHA-1-ADRENERGIC AND ALPHA-2-ADRENERGIC RECEPTORS [J].
BYLUND, DB .
FASEB JOURNAL, 1992, 6 (03) :832-839
[3]   DOPAMINE FAILS TO INHIBIT RENAL TUBULAR SODIUM-PUMP IN HYPERTENSIVE RATS [J].
CHEN, CJ ;
BEACH, RE ;
LOKHANDWALA, MF .
HYPERTENSION, 1993, 21 (03) :364-372
[4]  
CHENG YC, 1973, BIOCHEM PHARMACOL, V22, P3089
[5]  
FENG F, 1991, J PHARMACOL EXP THER, V258, P263
[6]  
HAN C, 1987, MOL PHARMACOL, V32, P505
[7]  
HAN C, 1990, MOL PHARMACOL, V37, P903
[8]   EXPRESSION OF RENAL ALPHA-1-ADRENERGIC RECEPTOR SUBTYPES IN ESTABLISHED HYPERTENSION [J].
JACKSON, CA ;
MICHEL, MC ;
INSEL, PA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 (06) :857-862
[9]  
JAGADEESH G, 1987, J PHARMACOL EXP THER, V243, P430
[10]  
KLIJN K, 1991, MOL PHARMACOL, V39, P407